JP2023512489A5 - - Google Patents
Info
- Publication number
- JP2023512489A5 JP2023512489A5 JP2022543653A JP2022543653A JP2023512489A5 JP 2023512489 A5 JP2023512489 A5 JP 2023512489A5 JP 2022543653 A JP2022543653 A JP 2022543653A JP 2022543653 A JP2022543653 A JP 2022543653A JP 2023512489 A5 JP2023512489 A5 JP 2023512489A5
- Authority
- JP
- Japan
- Prior art keywords
- increased
- chronic obstructive
- pulmonary disease
- obstructive pulmonary
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062962343P | 2020-01-17 | 2020-01-17 | |
| US62/962,343 | 2020-01-17 | ||
| US202063126920P | 2020-12-17 | 2020-12-17 | |
| US63/126,920 | 2020-12-17 | ||
| PCT/US2021/013763 WO2021146648A1 (en) | 2020-01-17 | 2021-01-16 | Compositions for managing chronic obstructive pulmonary disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023512489A JP2023512489A (ja) | 2023-03-27 |
| JP2023512489A5 true JP2023512489A5 (enExample) | 2024-01-24 |
| JP7746272B2 JP7746272B2 (ja) | 2025-09-30 |
Family
ID=76856592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022543653A Active JP7746272B2 (ja) | 2020-01-17 | 2021-01-16 | 慢性閉塞性肺疾患を管理するための組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11925606B2 (enExample) |
| EP (1) | EP4090340B1 (enExample) |
| JP (1) | JP7746272B2 (enExample) |
| KR (1) | KR20220128382A (enExample) |
| CN (1) | CN115175672B (enExample) |
| AU (1) | AU2021207536B2 (enExample) |
| BR (1) | BR112022014114A2 (enExample) |
| CA (1) | CA3164013A1 (enExample) |
| WO (1) | WO2021146648A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023554642A (ja) * | 2020-12-17 | 2023-12-28 | サミ－サビンサ グループ リミテッド | ビスデメトキシクルクミン組成物の抗肥満能 |
| WO2022203721A1 (en) * | 2021-03-25 | 2022-09-29 | Muhammed Majeed | Compositions and methods for inhibiting proteolytic activation of viruses |
| RS20220433A1 (sr) | 2022-05-11 | 2023-11-30 | Milan Prokin | Višeciljni antivirusni dodatak ishrani |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040266883A1 (en) * | 1999-10-27 | 2004-12-30 | Yale University | Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease |
| US20100179103A1 (en) * | 2008-07-21 | 2010-07-15 | Ketan Desai | Curcumin cyclodextrin combination for preventing or treating various diseases |
| US8486909B2 (en) * | 2009-06-24 | 2013-07-16 | Board Of Regents Of The University Of Nebraska | Compositions and methods for the diagnosis and treatment of inflammatory disorders and fibrotic disease |
| EP2475380A1 (en) * | 2009-09-11 | 2012-07-18 | Protaffin Biotechnologie AG | Composition for treatment of cxcl8-mediated lung inflammation |
| WO2012047674A2 (en) * | 2010-09-27 | 2012-04-12 | Microdose Therapeutx, Inc. | Methods and compositions for disease treatment using inhalation |
| ITMI20132169A1 (it) * | 2013-12-20 | 2015-06-21 | Thompson S R L | Composizione per la prevenzione ed il trattamento della bpco e della sintomatologia correlata |
| JP2017516764A (ja) * | 2014-04-18 | 2017-06-22 | オムニアクティブ ヘルス テクノロジーズ リミテッド | クルクミン組成物及びその使用 |
| WO2016145159A1 (en) * | 2015-03-10 | 2016-09-15 | The Research Foundation For The State University Of New York | Chemically modified curcumins for use in the production of lipoxins |
| JP6688009B2 (ja) * | 2015-04-15 | 2020-04-28 | 長谷川 浩二 | 酸化変性ｌｄｌ複合体抑制剤 |
| CN105998043B (zh) * | 2016-07-01 | 2018-11-27 | 吉林大学 | 槐属双苷在制备防治慢性阻塞性肺疾病药物中的应用 |
-
2021
- 2021-01-16 WO PCT/US2021/013763 patent/WO2021146648A1/en not_active Ceased
- 2021-01-16 US US17/151,121 patent/US11925606B2/en active Active
- 2021-01-16 BR BR112022014114A patent/BR112022014114A2/pt unknown
- 2021-01-16 JP JP2022543653A patent/JP7746272B2/ja active Active
- 2021-01-16 AU AU2021207536A patent/AU2021207536B2/en active Active
- 2021-01-16 EP EP21741037.2A patent/EP4090340B1/en active Active
- 2021-01-16 KR KR1020227027330A patent/KR20220128382A/ko active Pending
- 2021-01-16 CA CA3164013A patent/CA3164013A1/en active Pending
- 2021-01-16 CN CN202180015345.2A patent/CN115175672B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sahebnasagh et al. | Neutrophil Elastase inhibitor (Sivelestat), may be a promising therapeutic option for Management of Acute Lung Injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19 | |
| ATE511847T1 (de) | Pharmazeutische zubereitung für die behandlung entzündlicher erkrankungen des urogenitaltraktes | |
| JP2012529523A5 (enExample) | ||
| Rong et al. | Mahuang-Xixin-Fuzi decoction reduces the infection of influenza A virus in Kidney-Yang deficiency syndrome mice | |
| WO2007109118A3 (en) | RECOMBINANT HUMAN CC 10 (rhCC10) FOR TREATMENT OF RESPIRATORY DISORDERS | |
| WO2021191900A1 (en) | Methods for treating infectious diseases caused by coronavirus | |
| Hiramoto et al. | Evidence-based analysis: postoperative gastric bleeding: etiology and prevention | |
| EP4090340B1 (en) | Compositions comprising bisdemethoxycurcumin for managing chronic obstructive pulmonary disease | |
| CN116617249B (zh) | 铁皮石斛茎/叶多糖的应用 | |
| CN103720650A (zh) | 一种具有抗流感病毒作用的黄芩苷注射剂 | |
| DePace et al. | Long-COVID syndrome: a multi-organ disorder | |
| WO2016150151A1 (zh) | 青蒿琥酯在制备治疗中晚期脓毒症药物中的运用 | |
| US12433913B2 (en) | Treatment of acute respiratory disease syndrome (ARDS) with polysulfated polysaccharides | |
| CN101057840B (zh) | Vam3在制备治疗慢性阻塞性肺疾病的药物中的应用 | |
| CN118161478B (zh) | 肥大细胞抑制剂在制备防治猪繁殖与呼吸综合征早期感染药物中的应用 | |
| RU2191024C1 (ru) | Ингаляционный препарат, купирующий удушье при бронхиальной астме и бронхоспазме | |
| Jayaweera et al. | Recovery and survival in covid-19 respiratory failure, when treated with aviptadil | |
| RU2772701C1 (ru) | Способы лечения инфекционных заболеваний, вызванных коронавирусом | |
| CN110051682A (zh) | 圆柏属植物多糖在制备防治病毒性急性肺损伤的药物中的用途 | |
| Chapman | Adult respiratory distress syndrome—An update | |
| CN118512426A (zh) | 一种和厚朴酚在制备治疗肺损伤药物中的应用 | |
| KR102404684B1 (ko) | 인슐린 유사 성장인자 2 억제제를 포함하는 만성 폐질환의 예방 또는 치료용 조성물 | |
| WO2022221602A3 (en) | Compositions and methods for treating and/or preventing lung injury | |
| CA3171360A1 (en) | Use of bacterial compositions in the treatment and prophylaxis of airway diseases | |
| CN101167839A (zh) | 治疗和预防慢性阻塞性肺病的金荞麦复方制剂及用途 |